Metabolic outcomes 2 years following gastric bypass surgery in people with type 2 diabetes: An observational cohort study

QJM: An International Journal of Medicine

Volumn 107, Issue 9, 2014, Pages 721-726

  Behbehani, F ^a,b   Ammori, B J ^a,b   New, J P ^a,b   Summers, L K M ^a,b   Soran, H ^a,c   Syed, A A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; COHORT ANALYSIS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD; BLOOD PRESSURE; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; FOLLOW UP; GLUCOSE BLOOD LEVEL; MIDDLE AGED; OBESITY; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 84906836568     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu060     Document Type: Article

References (21)

1. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17:961-9.
2. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122:481-6.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4-14.
4. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13:1-190,215-357, iii-iv.
5. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis 2005; 1:371-81.
6. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23:427-36.
7. Burns EM, Naseem H, Bottle A, Lazzarino AI, Aylin P, Darzi A, et al. Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ 2010; 341:c4296.
8. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248-56.e5.
9. LeffDR, Heath D. Surgery for obesity in adulthood. BMJ 2009; 339:b3402.
10. Demssie YN, Jawaheer J, Farook S, New JP, Syed AA. Metabolic outcomes 1 year after gastric bypass surgery in obese people with type 2 diabetes. Med Princ Pract 2012; 21:125-8.
11. Alatishe A, Ammori BJ, New JP, Syed AA. Bariatric surgery in women of childbearing age. Q J Med 2013; 106:717-20.
12. Oria HE, Carrasquilla C, Cunningham P, Hess DS, Johnell P, Kligman MD, et al. Guidelines for weight calculations and follow-up in bariatric surgery. Surg Obes Relat Dis 2005; 1:67-8.
13. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care 2009; 32:2133-5.
14. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54:2506-14.
15. Cummings DE, Overduin J, Shannon MH, Foster-Schubert KE. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg Obes Relat Dis 2005; 1:358-68.
16. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, Marin JL, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidlyobese subjects. J Clin Endocrinol Metab 2006; 91:1735-40.
17. De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver 2012; 6:10-20.
18. Vilsboll T. The effects of glucagon-like peptide-1 on the beta cell. Diabetes Obes Metab 2009; 11(Suppl. 3):11-8.
19. Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 2011; 7:691-6.
20. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741-52.
21. Behbehani F, Ammori BJ, New JP, Summers LKM, Syed AA. Glycaemic and metabolic outcomes following bariatric surgery in obese people with type 2 diabetes. In Bariatric management. Diabet Med 2013; 30(Suppl. 1):12-3.